457 (Carbidopa and Levodopa Extended Release 50 mg / 200 mg)
Pill with imprint 457 is Beige, Elliptical / Oval and has been identified as Carbidopa and Levodopa Extended Release 50 mg / 200 mg. It is supplied by Caraco Pharmaceutical Laboratories.
Carbidopa/levodopa is used in the treatment of parkinson's disease; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 50 mg / 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 457
Carbidopa and Levodopa Extended Release
- Imprint
- 457
- Strength
- 50 mg / 200 mg
- Color
- Beige
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Caraco Pharmaceutical Laboratories
- National Drug Code (NDC)
- 62756-0457
Related Images for "457"
More about carbidopa / levodopa
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- 74 Reviews
- Drug class: dopaminergic antiparkinsonism agents
Consumer resources
- Carbidopa and levodopa
- Carbidopa and levodopa enteral
- Carbidopa and levodopa (Advanced Reading)
- Carbidopa and Levodopa Extended-Release Tablets
- Carbidopa and Levodopa Extended-Release Capsules
- ... +3 more
Other brands: Sinemet, Rytary, Sinemet CR, Duopa, Parcopa
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
